Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion type Assertion NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_head.
- NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion description "[Since 5-10% of transitional cell carcinomas (TCCs) have been shown to contain a mutated HRAS gene, and protein expression levels of all forms of HRAS have been correlated with TCC progression, we chose to study the contribution of the HRAS oncogene in bladder tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_provenance.
- NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion evidence source_evidence_literature NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_provenance.
- NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion SIO_000772 2247480 NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_provenance.
- NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion wasDerivedFrom befree-20150227 NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_provenance.
- NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_assertion wasGeneratedBy ECO_0000203 NP464733.RAvUjmGQDzqAgJIZ_W45WbdLXc8vBLM9ioUTUE1b_Mifo130_provenance.